Evidence map›Paper›PMID 42363194›Full record

ArticleGlobalization and health2026

Global norms, local institutions: a controlled comparative case study of WHO essential medicines policy adoption in Eastern Europe.

Kristina Jenei, Elias Mossialos, Huseyin Naci

Abstract readComparative Study
In one paragraph

Article in Globalization and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kristina JeneiDepartment of Health Policy, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, UK. k.jenei@lse.ac.uk.
Elias MossialosDepartment of Health Policy, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, UK.
Huseyin NaciDepartment of Health Policy, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo improve equitable access to medicines and avoid inefficient pharmaceutical spending, the World Health Organization (WHO) has long promoted five core principles regarding the selection of medicines for reimbursement: 1) the establishment of a national essential medicines list (NEML); 2) a diverse, independent selection committee; 3) an evidence-based methodology for selecting medicines; 4) integration with clinical guidelines; and 5) monitoring of use and expenditure. While many countries have formally adopted these principles, their integration into financing and procurement systems varies widely. Using Kingdon's Multiple Streams Approach (MSA) and the policy transfer framework, this study compares how WHO selection principles were adopted in two Eastern European countries: Ukraine (higher adopter) and Moldova (lower adopter).

resultsBoth countries established NEMLs aligned with WHO guidance, but only Ukraine more fully embedded these principles into pharmaceutical governance. Higer adoption in Ukraine is associated with sustained donor engagement, reform momentum, and domestic leadership. In Moldova, adoption remained largely absent, associated with weak institutional capacity and episodic donor support limiting integration.

conclusionsThis study illustrates how international guidance interacts with political windows, domestic will, and patterns of donor engagement to shape reform trajectories. The findings suggest that global health guidance is most influential when coupled with long-term technical support, local champions, and mechanisms for institutional continuity, helping to move reforms towards meaningful system change.

Indexed as

Drugs, EssentialHealth PolicyWorld Health OrganizationEurope, EasternHumansMoldovaUkraineDrugs, EssentialAccess to essential medicinesEastern European health systemsEssential medicinesGlobal health governanceHealth reformInstitutional legaciesInternational organizationsMoldovaNational essential medicines listsNorm adoptionPharmaceutical governancePharmaceutical policyPolicy transferPoliticsUkraineUniversal health coverageWorld Health Organization

Identifiers

PMID42363194
PMCPMC13563743

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.